Search for: "Teva Pharmaceuticals USA Inc" Results 161 - 180 of 422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Apr 2017, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
26 Jan 2015, 10:37 am by Dennis Crouch
The Judgments are vacated, and the cases are remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Teva Pharmaceuticals USA, Inc., v. [read post]
2 Jun 2011, 6:02 am by John Elwood
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
17 Oct 2014, 7:23 am by Amy Howe
At Bloomberg View, Noah Feldman analyzes Wednesday’s oral argument in the patent case Teva Pharmaceuticals USA v. [read post]
14 Feb 2022, 9:38 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 18-1976 (Fed. [read post]
13 Jul 2018, 5:48 pm by Lawrence B. Ebert
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
21 Jan 2013, 7:27 am by Lawrence B. Ebert
Food and Drug Administration said Wednesday the product, Budeprion XL 300 milligrams, which is manufactured by Impax Laboratories Inc. and marketed by Teva Pharmaceuticals USA Inc., "is not therapeutically equivalent to Wellbutrin XL 300 mg" or the extended-release version of Wellbutrin.In a post titled A Drug Recall That Should Frighten Us All About The FDA The People’s Pharmacy, a well-known syndicated radio and newspaper columnist husband and… [read post]
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
20 Feb 2013, 7:37 am by Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
23 Jan 2024, 3:43 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 23-768 (Supreme Court). [read post]
29 Mar 2016, 7:21 am by Green and Associates
Reinstein agreed to switch his patients to the generic version, but only after its manufacturers, Teva Pharmaceuticals USA Inc. and IVAX Pharmaceuticals LLC, agreed to pay him a consulting fee and finance a Clozapine research study performed by a Reinstein-affiliated entity. [read post]
21 Apr 2014, 6:01 am by Jon Gelman
The cost for medical delivery far exceeds indemnification for temporary and permanent disability benefits.The court's action, albeit temporary in nature, maybe a signal of forthcoming judicial intervention in the pharmaceutical arena that will result in a more realistic cost for pharmaceutical benefits in workers' compensation.Teva Pharmaceuticals USA, Inc., et al., Petitioners v.Sandoz, Inc., et al. [read post]